Doctors, as far back as the mid-19th century, noticed the connections between psoriasis and arthritis that occurred in some of their patients. However, this condition of “psoriatic arthritis” did not receive a clinical definition until the 1960s, when it was distinguished from rheumatoid arthritis. Part of the difficulty with understanding psoriatic arthritis relates to a […]

Exercise does a body good. In terms of cancer, there is already a substantial amount of evidence that staying active reduces the risk of developing cancer, including colon, breast, and endometrial cancers. Now, experts are excited about the connection between exercise and better outcomes for people who have been diagnosed with cancer. For the first […]

Evidence-based medicine calls for ongoing research and refinement of best practices for treating various diseases. In this spirit, a multi-disciplinary panel recently convened to develop recommendations for disease-modifying therapy for those with multiple sclerosis. This panel certainly was busy, in all they developed 30 recommendations; 17 of which related to when/how to start on disease-modifying […]

Breast cancer treatments have made impressive strides in terms of increasing survival rates for patients; however, a huge new study reveals that chemotherapy may not be as important of a factor for some women with breast cancer as previously thought. In fact, in some categories of breast cancer, most patients who received chemotherapy may not […]

Xeljanz (tofacitinib) garnered a lot of interest back in 2012 when it was developed and approved for the treatment of rheumatoid arthritis. Then, in 2017, studies found that this oral medication also treated psoriatic arthritis and FDA approval was added for that indication. Last week, yet another FDA approval for Xeljanz came: this medication now […]

Multiple sclerosis is an autoimmune disease. The family of autoimmune diseases include such diseases as lupus, rheumatoid arthritis, Crohn’s disease, type 1 diabetes, and ulcerative colitis. Unfortunately, someone with one autoimmune disease has an increased risk of also developing a second disease in this category. For example, there is a trend for someone with multiple […]

Scroll to Top